Stockholm - Delayed Quote SEK
Annexin Pharmaceuticals AB (publ) (ANNX.ST)
30.10
-0.90
(-2.90%)
At close: June 13 at 5:29:34 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-44,942
-50,228
-43,401
-41,165
-45,024
Investing Cash Flow
0
0
96
-260
0
Financing Cash Flow
82,144
45,151
33,608
23,060
76,371
End Cash Position
45,072
16,337
21,415
31,114
49,479
Issuance of Capital Stock
78,719
40,056
26,503
23,107
66,662
Issuance of Debt
5,000
5,000
10,000
0
20,000
Repayment of Debt
0
0
0
0
0
Free Cash Flow
-44,942
-50,228
-43,401
-41,165
-45,024
12/31/2021 - 4/19/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
688163.SS Shanghai Serum Bio-Technology Co., Ltd.
19.97
-4.40%
BT3.BE Lineage Cell Therapeutics Inc
0.5850
-0.85%
GXE.F Galapagos NV
24.76
+0.08%
AB3A.MU Sarepta Therapeutics Inc
31.82
-1.18%
ITRX inTerra Resources Corp
0.0240
0.00%
GENSY Genus plc
24.34
0.00%
8QQ.BE AbCellera Biologics Inc
2.5800
-6.99%
300759.SZ Pharmaron Beijing Co., Ltd.
24.84
-2.47%
AYJ.HA Valneva SE
2.6180
-4.10%
ONCIN.OL Oncoinvent ASA
1.8500
-8.64%